News Overview

Record date for distribution is 18 May 2022

The drug major has received final approval from the US drug regulator for its Abbreviated New Drug Application (ANDA) for generic Mesalamine extended release capsules, 500 mg.

COMEX Gold dropped to its lowest level in three months, pressured by a strong US dollar intruding into fresh two-decade highs. The dollar index soared to 104.93, hitting new 20-year peaks on renewed worries of aggressive tightening by Federal Reserve following hot inflation data coupled with heightened risks surrounding the Russian invasion of Ukraine, that led investors to fly for safety. Russia has said it […]

Sales decline 10.53% to Rs 13.59 crore

WTI crude futures resumed uptrend on Friday, after hitting lows of around $106.29 levels in the previous session and $98.22 during the week amid renewed growth concerns on rising China Covid cases and ensuing lockdown to hit demand from the top crude importer and escalating Russia-Ukraine war. Crude oil futures rebounded to above $107 per barrel. Meanwhile, slower global economic growth, Chinas fight against COVID, […]

Sun Pharmaceutical Industries: The drug major has received final approval from USFDA for its Abbreviated New Drug Application (ANDA) for generic Mesalamine extended release capsules, 500 mg. The generic product approval is based on Pentasa Extended Release Capsules, 500mg as a reference product. As per March 2022 IQVIA Health data, Pentasa extended release capsules, 500mg had annualized sales of approximately $213 million in USA. Zydus […]

Retail investors showed interest in the IPO as the portion set aside for them was subscribed 7.52 times.

SGX Nifty: Trading of Nifty 50 index futures on the Singapore stock exchange indicates that the Nifty could rise 176 points at the opening bell. Global Markets: The US Dow Jones index futures were up 176 points, indicating a strong opening in the US stocks on Friday. Asian shares edged higher on Friday after a late recovery helped US stocks cut losses overnight. In China, […]

Sales rise 48.99% to Rs 178.13 crore

Sales rise 18.54% to Rs 38.69 crore